| Decision | Consent granted Section 13(1)(a) Overseas Investment Act 2005 |
|---|---|
| Decision maker | Toitū Te Whenua Land Information New Zealand |
| Decision date | 20 September 2024 |
| Pathway | Significant business assets only |
| Investment | Acquisition of up to 100% of Cubro Holdings Limited. |
| Consideration | Withheld under sections 9(2)(a) and 9(2)(b)(ii) of the Official Information Act 1982 |
| Applicant | Bunzl New Zealand Holdings (No. 2) Limited United Kingdom 37% United States of America 29% Canada 12% Various 22% |
| Vendor | Shareholders of Cubro Holdings Limited New Zealand 100% |
| Background | The Applicant is ultimately owned by Bunzl plc, the specialist international distribution and services Group. The Applicant is the holding company for the Bunzl Group’s MedTech and specialist healthcare businesses in New Zealand. Cubro Holdings Limited is a healthcare equipment provider. Cubro Holdings Limited and its subsidiaries provide healthcare equipment and modular operating theatres in New Zealand, Australia and the South Pacific (including Tonga and Fiji). Consent was granted as the Applicant met the investor test criterion. |
| More information | Tessa Baker Chapman Tripp (Auckland) PO Box 2206 Auckland 1140 |